Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death
Christian Holkmann Olsen(Hvidovre Hospital), M Fisher(Brighton General Hospital), Christine Katlama(Université Paris Cité), Ole Kirk(University of Copenhagen), Amanda Mocroft(University of Copenhagen), Stefano Vella, Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Nathan Clumeck(Centre Hospitalier Universitaire de Saint-Pierre), Anders Blaxhult(The Royal Free Hospital), AN Phillips(The Royal Free Hospital)
Cited by 87
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Treatment for Adult HIV Infection
|JAMA|2006|1k